If you’re confused about all those drug pricing proposals

That means two things: One, you’re just as qualified to write a biotech email newsletter as the person typing this sentence, and, two, you’re in luck.

Introducing STAT’s Drug Pricing Policy Tracker, a living document from our D.C. correspondents that lists and explains every White House promise, congressional effort, and FDA working group meant to bring down the cost of medicine in the U.S.

If you’ve ever wondered what CREATES stands for, how a nation gets most favored, or which proposals actually stand a chance of passing a divided Congress, consider this your go-to cheat sheet as we wend toward the 2020 election.

Read more.